Alnylam Pharmaceuticals
ALNY
ALNY
398 hedge funds and large institutions have $19B invested in Alnylam Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 139 increasing their positions, 131 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2% more ownership
Funds ownership: 93.49% → 95.49% (+2%)
6% more call options, than puts
Call options by funds: $269M | Put options by funds: $253M
6% more repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 131
Holders
398
Holding in Top 10
9
Calls
$269M
Puts
$253M
Top Buyers
| 1 | +$185M | |
| 2 | +$170M | |
| 3 | +$160M | |
| 4 |
Holocene Advisors
New York
|
+$94.1M |
| 5 |
JPMorgan Chase & Co
New York
|
+$69.5M |
Top Sellers
| 1 | -$85.4M | |
| 2 | -$54.3M | |
| 3 | -$53.6M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$39.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$36.3M |